Skip to content
healthcare.dev

Elzonris

NDC 72187-0401, tagraxofusp, injection, solution, from Stemline Therapeutics, Inc..

Product NDC
72187-0401
Status
Listed
Labeler
Stemline Therapeutics, Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761116
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72187-0401 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TAGRAXOFUSP1000 ug/mL

Pharmacologic classes

CD123 Interaction [EPC]; CD123 Interactions [MoA]; Cytotoxin [EPC]; Cytotoxins [CS]

Package NDCNDC-11Package
72187-0401-1721870401011 VIAL, SINGLE-DOSE in 1 CARTON (72187-0401-1) / 1 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/80eb1080-fe20-4af0-b2a5-a67999923fa8
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=72187-0401

Use it

Look up 72187-0401 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72187-0401 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72187-0401. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.